Margaret Aileen Stefater-Richards, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastric Bypass | 10 | 2024 | 818 | 3.210 |
Why?
|
Gastrectomy | 6 | 2013 | 672 | 1.440 |
Why?
|
Obesity, Morbid | 4 | 2024 | 1277 | 1.030 |
Why?
|
Jejunum | 2 | 2024 | 472 | 0.910 |
Why?
|
Obesity | 12 | 2023 | 12938 | 0.840 |
Why?
|
Weight Loss | 8 | 2024 | 2683 | 0.830 |
Why?
|
Adaptation, Physiological | 2 | 2024 | 1301 | 0.720 |
Why?
|
Bariatric Surgery | 5 | 2018 | 992 | 0.710 |
Why?
|
Remission Induction | 1 | 2024 | 2395 | 0.630 |
Why?
|
Glucagon-Like Peptide 1 | 4 | 2019 | 364 | 0.580 |
Why?
|
Rats, Long-Evans | 6 | 2012 | 383 | 0.470 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2024 | 12143 | 0.460 |
Why?
|
Food Preferences | 2 | 2019 | 398 | 0.430 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2013 | 86 | 0.430 |
Why?
|
Leptin | 2 | 2012 | 1597 | 0.420 |
Why?
|
Glucokinase | 1 | 2012 | 102 | 0.410 |
Why?
|
Postprandial Period | 2 | 2011 | 315 | 0.410 |
Why?
|
Ciliary Neurotrophic Factor | 1 | 2012 | 77 | 0.400 |
Why?
|
Anorexia | 1 | 2012 | 154 | 0.400 |
Why?
|
Incretins | 1 | 2012 | 99 | 0.390 |
Why?
|
Appetite Depressants | 1 | 2012 | 108 | 0.390 |
Why?
|
Gastritis | 1 | 2013 | 199 | 0.380 |
Why?
|
Gastroplasty | 1 | 2012 | 157 | 0.350 |
Why?
|
Blood Glucose | 4 | 2023 | 6391 | 0.340 |
Why?
|
Metabolomics | 1 | 2019 | 1657 | 0.340 |
Why?
|
Energy Metabolism | 5 | 2012 | 2881 | 0.340 |
Why?
|
Dietary Fats | 3 | 2012 | 1994 | 0.340 |
Why?
|
Diet Therapy | 1 | 2010 | 150 | 0.330 |
Why?
|
Body Weight | 5 | 2012 | 4618 | 0.330 |
Why?
|
Insulin Resistance | 3 | 2021 | 3963 | 0.330 |
Why?
|
Weight Gain | 1 | 2019 | 2347 | 0.320 |
Why?
|
Fasting | 1 | 2012 | 1602 | 0.270 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3441 | 0.260 |
Why?
|
Glucose | 3 | 2018 | 4347 | 0.240 |
Why?
|
Eating | 4 | 2012 | 1538 | 0.240 |
Why?
|
Osteoporosis | 1 | 2013 | 1605 | 0.220 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 77 | 0.220 |
Why?
|
Triglycerides | 1 | 2011 | 2460 | 0.220 |
Why?
|
Rats | 7 | 2019 | 23742 | 0.210 |
Why?
|
Central Nervous System | 1 | 2010 | 1337 | 0.210 |
Why?
|
Lipogenesis | 1 | 2024 | 214 | 0.210 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5840 | 0.200 |
Why?
|
Homeostasis | 2 | 2011 | 3321 | 0.180 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2871 | 0.170 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3030 | 0.170 |
Why?
|
Lipids | 1 | 2011 | 3340 | 0.170 |
Why?
|
Enteral Nutrition | 1 | 2024 | 792 | 0.150 |
Why?
|
Hypoglycemia | 2 | 2017 | 884 | 0.150 |
Why?
|
Follistatin | 1 | 2018 | 137 | 0.140 |
Why?
|
Stomach | 2 | 2011 | 696 | 0.140 |
Why?
|
Insulin | 3 | 2021 | 6602 | 0.130 |
Why?
|
Methadone | 1 | 2017 | 321 | 0.120 |
Why?
|
Dumping Syndrome | 1 | 2012 | 18 | 0.110 |
Why?
|
Animals | 11 | 2019 | 168441 | 0.110 |
Why?
|
Ciliary Neurotrophic Factor Receptor alpha Subunit | 1 | 2012 | 4 | 0.100 |
Why?
|
Neurons | 1 | 2012 | 9462 | 0.100 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2012 | 85 | 0.100 |
Why?
|
Ribonucleotides | 1 | 2012 | 114 | 0.100 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 2012 | 114 | 0.100 |
Why?
|
Diet | 2 | 2020 | 8074 | 0.100 |
Why?
|
Critical Illness | 1 | 2024 | 2723 | 0.090 |
Why?
|
Vitamin B Complex | 1 | 2013 | 299 | 0.090 |
Why?
|
Taste | 1 | 2012 | 189 | 0.090 |
Why?
|
Receptors, Leptin | 1 | 2012 | 350 | 0.090 |
Why?
|
Vitamin B 12 | 1 | 2013 | 524 | 0.090 |
Why?
|
Adolescent Health Services | 1 | 2012 | 218 | 0.090 |
Why?
|
Bone Density | 2 | 2013 | 3551 | 0.080 |
Why?
|
Agouti-Related Protein | 1 | 2010 | 93 | 0.080 |
Why?
|
Hyperglycemia | 1 | 2018 | 1376 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2018 | 14409 | 0.080 |
Why?
|
Malabsorption Syndromes | 1 | 2010 | 135 | 0.080 |
Why?
|
Neuropeptide Y | 1 | 2010 | 192 | 0.080 |
Why?
|
Humans | 15 | 2024 | 761423 | 0.080 |
Why?
|
Male | 11 | 2024 | 360736 | 0.080 |
Why?
|
Physical Conditioning, Animal | 1 | 2012 | 365 | 0.080 |
Why?
|
Hormones | 1 | 2012 | 869 | 0.080 |
Why?
|
STAT3 Transcription Factor | 1 | 2012 | 871 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1750 | 0.070 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1737 | 0.070 |
Why?
|
Prospective Studies | 2 | 2023 | 54415 | 0.070 |
Why?
|
Gene Expression Regulation | 1 | 2024 | 11902 | 0.070 |
Why?
|
Hyperlipidemias | 1 | 2011 | 771 | 0.070 |
Why?
|
Postoperative Care | 1 | 2012 | 1471 | 0.070 |
Why?
|
Pilot Projects | 1 | 2019 | 8633 | 0.060 |
Why?
|
Choice Behavior | 1 | 2012 | 824 | 0.060 |
Why?
|
Heterozygote | 1 | 2012 | 2803 | 0.060 |
Why?
|
Protein Kinases | 1 | 2012 | 1607 | 0.060 |
Why?
|
Age of Onset | 1 | 2012 | 3304 | 0.060 |
Why?
|
Gastroesophageal Reflux | 1 | 2012 | 817 | 0.060 |
Why?
|
Hypothalamus | 1 | 2010 | 999 | 0.060 |
Why?
|
Fatty Liver | 1 | 2011 | 789 | 0.060 |
Why?
|
Reward | 1 | 2012 | 971 | 0.060 |
Why?
|
Adolescent | 3 | 2021 | 88313 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10762 | 0.060 |
Why?
|
Adult | 4 | 2024 | 221148 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2017 | 64651 | 0.060 |
Why?
|
Female | 6 | 2024 | 392581 | 0.050 |
Why?
|
Comorbidity | 1 | 2017 | 10498 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2011 | 1902 | 0.050 |
Why?
|
Liver | 1 | 2018 | 7532 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2011 | 18247 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2010 | 2057 | 0.050 |
Why?
|
Phosphorylation | 1 | 2012 | 8320 | 0.050 |
Why?
|
Signal Transduction | 3 | 2018 | 23441 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2013 | 3414 | 0.040 |
Why?
|
Calcium | 1 | 2013 | 5727 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2012 | 3187 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9535 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11073 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2024 | 832 | 0.040 |
Why?
|
Risk Factors | 2 | 2017 | 74167 | 0.040 |
Why?
|
3T3-L1 Cells | 1 | 2018 | 209 | 0.040 |
Why?
|
Middle Aged | 2 | 2024 | 220826 | 0.040 |
Why?
|
Mice | 3 | 2018 | 81509 | 0.040 |
Why?
|
Nutritional Status | 1 | 2024 | 1613 | 0.030 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1199 | 0.030 |
Why?
|
Prevalence | 1 | 2012 | 15717 | 0.030 |
Why?
|
Body Mass Index | 1 | 2013 | 12951 | 0.030 |
Why?
|
Adipose Tissue, White | 1 | 2018 | 365 | 0.030 |
Why?
|
Naloxone | 1 | 2017 | 370 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2018 | 575 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1612 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 26212 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39117 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2918 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15650 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42254 | 0.020 |
Why?
|
Aged | 1 | 2019 | 169235 | 0.020 |
Why?
|
Young Adult | 1 | 2012 | 59207 | 0.020 |
Why?
|
Child | 1 | 2012 | 80162 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22163 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36205 | 0.010 |
Why?
|